英文名称 |
中文名称 |
CAS号 |
操作 |
Hematein |
氧化苏木精 |
475-25-2 |
详细
|
WYE-354 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 |
1062169-56-5 |
详细
|
GSK1059615 |
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 |
958852-01-2 |
详细
|
Rigosertib sodium |
瑞格色替钠 |
592542-60-4 |
详细
|
Rigosertib |
瑞格色替 |
592542-59-1 |
详细
|
KU-60019 |
KU 60019 |
925701-46-8 |
详细
|
PHT-427 |
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 |
1191951-57-1 |
详细
|
JR-AB2-011 |
JR-AB2-011 |
2411853-34-2 |
详细
|
STL127705 |
化合物STL127705 |
1326852-06-5 |
详细
|
Umbralisib hydrochloride |
1532533-78-0 |
1532533-78-0 |
详细
|
Serabelisib |
[6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮 |
1268454-23-4 |
详细
|
Borussertib |
Borussertib |
1800070-77-2 |
详细
|
BX517 |
PDK1 INHIBITOR |
850717-64-5 |
详细
|
(R)-PS210 |
Propanedioic acid, 2-[(1R)-3-oxo-1-phenyl-3-[4-(trifluoroMethyl)phenyl]propyl]- |
1410101-89-1 |
详细
|
PF-4989216 |
4-(4-氰基-2-氟苯基)-2-吗啉-5-(1H-1,2,4-三唑-5-基)噻吩-3-腈 |
1276553-09-3 |
详细
|
Taselisib |
GDC 0032 |
1282512-48-4 |
详细
|
GSK-3 inhibitor 1 |
3-(9-氟-1,2,3,4-四氢吡咯并[3,2,1-JK][1,4]苯并二氮杂卓-7-基)-4-咪唑并[1,2-A]吡啶-3-基-1H-吡咯-2,5-二酮单盐酸盐 |
603272-51-1 |
详细
|
MP7 |
PDK1 抑制剂 |
1001409-50-2 |
详细
|
Palomid 529 |
PALOMID 529 (P529) |
914913-88-5 |
详细
|
GSK2334470 |
GSK2334470 |
1227911-45-6 |
详细
|
Dactolisib Tosylate |
BEZ235 对甲苯磺酸盐 |
1028385-32-1 |
详细
|
PF-04691502 |
2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1013101-36-4 |
详细
|
Buparlisib Hydrochloride |
BKM120(盐酸盐) |
1312445-63-8 |
详细
|
Ipatasertib dihydrochloride |
(2S)-2-(4-氯苯基)-1-[4-[(5R,7R)-6,7-二氢-7-羟基-5-甲基-5H-环戊并嘧啶-4-基]-1-哌嗪基]-3-[(1-甲基乙基)氨基]-1-丙酮二盐酸盐 |
1396257-94-5 |
详细
|
Alpelisib |
阿培利司 |
1217486-61-7 |
详细
|
GSK2636771 |
GSK2636771 |
1372540-25-4 |
详细
|
GDC-0349 |
N-ETHYL-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲 |
1207360-89-1 |
详细
|
WYE-687 dihydrochloride |
WYE-687二盐酸盐 |
1702364-87-1 |
详细
|
CZC24832 |
5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺 |
1159824-67-5 |
详细
|
Copanlisib dihydrochloride |
Copanlisib |
1402152-13-9 |
详细
|
BIO-acetoxime |
6-溴靛玉红-3'-丙酮肟 |
667463-85-6 |
详细
|
FPA-124 |
AKT 抗化剂 |
902779-59-3 |
详细
|
CH5132799 |
CH5132799 |
1007207-67-1 |
详细
|
OTSSP167 hydrochloride |
OTSSP 167 盐酸盐 |
1431698-10-0 |
详细
|
CGK733 |
CGK 733 |
905973-89-9 |
详细
|
KP-23172 |
6H-INDENO[1,2-E]TETRAZOLO[1,5-B][1,2,4]TRIAZIN-6-ONE |
1374996-60-7 |
详细
|
IM-12 |
IM-12 |
1129669-05-1 |
详细
|
AZD8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
详细
|
ON 146040 |
1404231-34-0 |
1404231-34-0 |
详细
|
ETP-46321 |
CS-2500 |
1252594-99-2 |
详细
|
JNJ-47117096 hydrochloride |
1610536-69-0 |
1610536-69-0 |
详细
|
(R)-BRD3731 |
|
2056262-08-7 |
详细
|
BRD3731 |
5H-Pyrazolo[3,4-b]quinolin-5-one, 3-(2,2-dimethylpropyl)-1,2,4,6,7,8-hexahydro-4,7,7-trimethyl-4-phenyl-, (4S)- |
2056262-07-6 |
详细
|
Vps34-IN-2 |
(S)-1-(3-methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
1523404-29-6 |
详细
|
Rheb inhibitor NR1 |
化合物 T16741 |
2216763-38-9 |
详细
|
Samotolisib |
LY-3023414 |
1386874-06-1 |
详细
|
GSK-3β inhibitor 1 |
2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- |
187325-53-7 |
详细
|
Acalisib |
GS-9820 |
870281-34-8 |
详细
|
GNE-317 |
GNE-317 |
1394076-92-6 |
详细
|
Vps34-IN-1 |
VPS34-IN1 |
1383716-33-3 |
详细
|
Ampkinone |
CS-2123 |
1233082-79-5 |
详细
|
Bimiralisib |
PI3K/MTOR抑制剂 |
1225037-39-7 |
详细
|
AZD-8835 |
AZD-8835 |
1620576-64-8 |
详细
|
AMG319 |
AMG319 |
1608125-21-8 |
详细
|
PI4KIII beta inhibitor 3 |
4-(5-AMINO-2-PYRIDIN-3-YL-THIAZOLO[5,4-D]PYRIMIDIN-7-YL)-PIPERAZINE-1-CARBOXYLIC ACID P-TOLYLAMIDE |
1245319-54-3 |
详细
|
NU 7026 |
2-(4-吗啉基)-4H-萘并[1,2-B]吡喃-4-酮 |
154447-35-5 |
详细
|
SAR-260301 |
(S)-2-(2-(2-甲基吲哚啉-1-基)-2-氧代乙基)-6-吗啉嘧啶-4(3H)-酮 |
1260612-13-2 |
详细
|
HS-173 |
HS-173 |
1276110-06-5 |
详细
|
Voxtalisib |
VOXTALISIB |
934493-76-2 |
详细
|
Uprosertib |
UPROSERTIB |
1047634-65-0 |
详细
|
CAL-130 Hydrochloride |
2-[(1S)-1-[(2-氨基-9H-嘌呤-6-基)氨基]乙基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮盐酸盐 |
1431697-78-7 |
详细
|
LY2090314 |
LY 2090314 |
603288-22-8 |
详细
|
NVP-QAV-572 |
N-[2-[2-(2-氟乙基)-2H-四唑-5-基]乙基]-N'-[5-[3-氟-4-(甲基磺酰基)苯基]-4-甲基-2-噻唑基]脲 |
957209-68-6 |
详细
|
Phenformin hydrochloride |
盐酸苯乙福明 |
834-28-6 |
详细
|
Pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
详细
|
VS-5584 |
VS-5584 |
1246560-33-7 |
详细
|
CNX-1351 |
CNX1351 |
1276105-89-5 |
详细
|
3CAI |
2-氯-1-(1H-吲哚-3-基)-乙酮 |
28755-03-5 |
详细
|
ZLN024 hydrochloride |
ZLN-024 hydrochloride |
1883548-91-1 |
详细
|
Seletalisib |
UCB5857 |
1362850-20-1 |
详细
|
CC-223 |
CC-223 |
1228013-30-6 |
详细
|
CC-115 hydrochloride |
1300118-55-1 |
1300118-55-1 |
详细
|
Duvelisib |
IPI-145 |
1201438-56-3 |
详细
|
Duvelisib (R enantiomer) |
1261590-48-0 |
1261590-48-0 |
详细
|
GNF4877 |
GNF4877 |
2041073-22-5 |
详细
|
Torin 2 |
9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮 |
1223001-51-1 |
详细
|
Idelalisib |
艾代拉里斯 |
870281-82-6 |
详细
|
VO-Ohpic trihydrate |
VO-OHPIC 三水合物 |
476310-60-8 |
详细
|
GSK-3β inhibitor 2 |
GSK-3 β inhibitor 2 |
1702428-31-6 |
详细
|
KY19382 |
KY19382 |
2226664-93-1 |
详细
|
CCT128930 |
CCT128930 |
885499-61-6 |
详细
|
A66 |
A66 |
1166227-08-2 |
详细
|
BGT226 maleate |
NVP-BGT226 |
1245537-68-1 |
详细
|
AICAR phosphate |
5-氨基-1-核糖基咪唑-4-甲酰胺磷酸盐 |
681006-28-0 |
详细
|
Deguelin |
魚藤素 |
522-17-8 |
详细
|
AMG 511 |
(R)-4-(2-((5-氟-6-甲氧基吡啶-3-基)氨基)-5-(1-(4-(甲基磺酰基)哌嗪-1-基)乙基)吡啶-3-基)-6-甲基-1,3,5-三嗪-2-胺 |
1253573-53-3 |
详细
|
TG 100713 |
TG 100713,3-(2,4-DIAMINO-6-PTERIDINYL)-PHENOL |
925705-73-3 |
详细
|
CAY10505 |
CAY10505 |
1218777-13-9 |
详细
|
AS-604850 |
5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮 |
648449-76-7 |
详细
|
AS-252424 |
5-[[5-(4-氟-2-羟基苯基)-2-呋喃基]亚甲基]-2,4-噻唑烷二酮 |
900515-16-4 |
详细
|
MSC2360844 |
MSC2360844 |
1305267-37-1 |
详细
|
MSC2360844 hemifumarate |
|
1621688-31-0 |
详细
|
IM156 |
IM156 |
1422365-94-3 |
详细
|
SRX3207 |
7H-Thieno[3,2-b]pyran-7-one, 3-[4-[[4-[4-(1-azetidinylmethyl)-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]phenyl]-5-(4-morpholinyl)- |
2254693-15-5 |
详细
|
ATR inhibitor 2 |
2-氨基-6-氟-N-(5-氟-4-(4-(4-(噁丁环烷-3-基)哌嗪-1-羰基)哌啶-1-基)吡啶-3-基)吡唑并[1,5-A]嘧啶-3-甲酰胺 |
1613191-99-3 |
详细
|
ASP4132 |
(6-(1-((6-甲氧基吡啶-3-基)甲基)哌啶-4-基)-1H-苯并[D]咪唑-2-基)(4-(4-(三氟甲基)苄基)哌嗪-1-基)甲酮 双对甲苯磺酸盐 |
1640294-30-9 |
详细
|
PQR626 |
无中文名称 |
1927857-98-4 |
详细
|
TMBIM6 antagonist-1 |
1-(2-氨基苯基)-3-(3-硝基苯基)-2-丙烯-1-酮 |
123134-61-2 |
详细
|
SAR502250 |
SAR502250 |
503860-57-9 |
详细
|
XL388 |
[7-(6-氨基-3-吡啶基)-2,3-二氢-1,4-苯并氧氮杂卓-4(5H)-基][3-氟-2-甲基-4-(甲基磺酰基)苯基]-甲酮 |
1251156-08-7 |
详细
|